Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems.
Affiliation
Cancer Research Campaign Department of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, United Kingdom.Issue Date
1995-09
Metadata
Show full item recordAbstract
Interest in the isolation and characterization of primitive hemopoietic cells in both the clinical and research fields has rapidly increased. In parallel, different purification systems have been developed to isolate these cells. We have compared five different methods for separation of CD34+ cells from human umbilical cord blood, normal bone marrow and apheresis harvests and analyzed purity, recovery, yield and enrichment of colony forming cells (CFC) for each individual system. Our results indicate that the most reliable methods of purification for all samples were fluorescence activated cell sorting (FACS) and magnetic activated cell sorting (MACS) which consistently yielded high purities (> 70%) and enrichment of CFC. In this respect the enrichment of CFC from the MACS was superior to all the other systems including FACS. Similar results (> 70%) for purity were obtained using avidin affinity columns and a biotinylated antibody but neither yield nor CFC enrichment approached the values achieved with MACS. On average CFC enrichment using these affinity columns was greater than that observed for FACS while the purity was comparable. Both CELLector flasks and immunomagnetic beads coated with CD34 antibodies were less effective in our hands in separating purified populations of progenitor cells. Both purity and CFC enrichment of CD34+ cells using these methods were at least 50% lower than obtained with either FACS, MACS or affinity columns.Citation
Comparison of purity and enrichment of CD34+ cells from bone marrow, umbilical cord and peripheral blood (primed for apheresis) using five separation systems. 1995, 13 (5):524-32 Stem CellsJournal
Stem CellsDOI
10.1002/stem.5530130510PubMed ID
8528102Type
ArticleLanguage
enISSN
1066-5099ae974a485f413a2113503eed53cd6c53
10.1002/stem.5530130510
Scopus Count
Collections
Related articles
- Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
- Authors: Van Epps DE, Bender J, Lee W, Schilling M, Smith A, Smith S, Unverzagt K, Law P, Burgess J
- Issue date: 1994
- Multicentre European study comparing selection techniques for the isolation of CD34+ cells.
- Authors: de Wynter EA, Ryder D, Lanza F, Nadali G, Johnsen H, Denning-Kendall P, Thing-Mortensen B, Silvestri F, Testa NG
- Issue date: 1999 Jun
- Two CD34+ stem cells from umbilical cord blood enrichment methods.
- Authors: Pafumi C, Bosco P, Cavallaro A, Farina M, Leonardi I, Pernicone G, Bandiera S, Russo A, Giardina P, Chiarenza M, Calogero AE
- Issue date: 2002 Jun
- Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.
- Authors: de Wynter EA, Nadali G, Coutinho LH, Testa NG
- Issue date: 1996 Sep
- Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection.
- Authors: Nagler A, Peacock M, Tantoco M, Lamons D, Okarma TB, Okrongly DA
- Issue date: 1994 Nov